sergolexole has been researched along with 5-methoxytryptamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baez, M; Johnson, MP; Loncharich, RJ; Nelson, DL | 1 |
| Cohen, ML; Cushing, DJ | 1 |
2 other study(ies) available for sergolexole and 5-methoxytryptamine
| Article | Year |
|---|---|
Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
Topics: Amphetamines; Animals; Binding, Competitive; Cloning, Molecular; Ergolines; Humans; Hydrogen Bonding; Hydrolysis; Inositol Phosphates; Ketanserin; Mutation; Rats; Receptors, Serotonin; Species Specificity; Structure-Activity Relationship; Tryptamines | 1994 |
Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
Topics: 5-Methoxytryptamine; Animals; Coronary Vessels; Endothelium, Vascular; Ergolines; In Vitro Techniques; Lysergic Acid; Muscle Contraction; Muscle, Smooth, Vascular; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Swine | 1993 |